Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevel Collect Regulatory News (RBG)

  • There is currently no data for RBG

Form 8.5 (EPT/NON-RI)- REVOLUTION BARS GROUP PLC - Amendment

12 Sep 2017 14:21

FORM 8.5 (EPT/NON-RI) AMENDMENT TO SALES

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (“RI”) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:

BARCLAYS CAPITAL SECURITIES LTD

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

REVOLUTION BARS GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Stonegate Pub Company Limited

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

7 Sept 2017

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 0.1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 0 0.00% 0 0.00%
(2) Cash-settled derivatives:
0 0.00% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 0 0.00% 0 0.00%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
0.1p ordinary Sale 400 2.1025 GBP 2.1025 GBP
0.1p ordinary Purchase 400 2.1025 GBP 2.1025 GBP
(b) Cash-settled derivative transactions
Class of relevant Product Nature of dealing Number of Price per unit
security description reference
securities

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

12 Sept 2017

Contact name:

Jay Supaya

Telephone number:

0207 773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170912006108/en/

Copyright Business Wire 2017

Date   Source Headline
22nd Jun 20218:50 amRNSDirector/PDMR Shareholding
18th Jun 20218:06 amRNSHolding(s) in Company
15th Jun 20214:23 pmRNSDirector/PDMR Shareholding
15th Jun 20218:27 amRNSSchedule 2(g) Update
14th Jun 20212:31 pmRNSResult of GM, Director/PDMR, Total Voting Rights
14th Jun 20217:00 amRNSResult of Open Offer
27th May 20216:11 pmRNSPublication and Despatch of Circular
26th May 20217:00 amRNSResults of the Firm Placing and Placing
25th May 20214:44 pmRNSFirm Placing and Placing and Open Offer
19th May 20211:04 pmRNSHolding(s) in Company
11th May 20217:00 amRNSRe-opening Update
13th Apr 20217:00 amRNSInterim Results
4th Mar 20217:00 amRNSCOVID-19 Update/Notification Interim Results Date
15th Feb 202112:01 pmRNSResult of General Meeting
22nd Jan 20211:07 pmRNSNotice of GM
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:35 pmRNSPrice Monitoring Extension
24th Dec 202011:36 amRNSGrant of Options
22nd Dec 202012:30 pmRNSResult of AGM
21st Dec 20209:05 amRNSSecond Price Monitoring Extn
21st Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSPreliminary Results
10th Dec 20204:41 pmRNSSecond Price Monitoring Extn
10th Dec 20204:36 pmRNSPrice Monitoring Extension
27th Nov 20203:40 pmRNSNotice of 2020 Annual General Meeting
17th Nov 202011:40 amRNSHolding(s) in Company
16th Nov 20202:06 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
13th Nov 20202:37 pmRNSCVA successfully approved
9th Nov 20204:41 pmRNSSecond Price Monitoring Extn
9th Nov 20204:37 pmRNSPrice Monitoring Extension
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
28th Oct 20205:12 pmRNSHolding(s) in Company
28th Oct 20208:48 amRNSHolding(s) in Company
28th Oct 20208:41 amRNSHolding(s) in Company
27th Oct 20207:00 amRNSLaunch of CVA in subsidiary entity
12th Oct 202012:16 pmRNSHolding(s) in Company
6th Oct 20204:40 pmRNSHolding(s) in Company
1st Oct 20203:36 pmRNSHolding(s) in Company
28th Sep 202012:59 pmRNSHolding(s) in Company
25th Sep 20202:05 pmRNSSecond Price Monitoring Extn
25th Sep 20202:01 pmRNSPrice Monitoring Extension
25th Sep 202011:26 amRNSStatement re press speculation
18th Sep 20201:25 pmRNSHolding(s) in Company
9th Sep 20205:02 pmRNSHolding(s) in Company
8th Sep 202010:15 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update and FY results reporting date
21st Aug 202010:58 amRNSHolding(s) in Company
31st Jul 20202:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.